CDC Says Stroke Concerns Over Pfizer Jab Warrant Investigation

The Centers for Disease Control and Prevention (CDC) says that data collected on the Pfizer-BioNTech COVID-19 vaccine merits an investigation into potential stroke risks for people aged 65 and older.

“Following the availability and use of the updated (bivalent) COVID-19 vaccines, CDC’s Vaccine Safety Datalink (VSD), a near real-time surveillance system, met the statistical criteria to prompt additional investigation into whether there was a safety concern for ischemic stroke in people ages 65 and older who received the Pfizer-BioNTech COVID-19 Vaccine, Bivalent,” reads a Friday statement.

“Rapid-response investigation of the signal in the VSD raised a question of whether people 65 and older who have received the Pfizer-BioNTech COVID-19 Vaccine, Bivalent were more likely to have an ischemic stroke in the 21 days following vaccination compared with days 22-44 following vaccination,” the release continues.

The bivalent vaccine includes “a component of the original virus strain to provide broad protection against COVID-19 and a component of the omicron variant to provide better protection against COVID-19 caused by the omicron variant,” according to the FDA. – READ MORE